ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Update

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the recipient of a significant drop in short interest in February. As of February 13th, there was short interest totaling 10,921 shares, a drop of 48.1% from the January 29th total of 21,029 shares. Based on an average daily trading volume, of 17,953 shares, the days-to-cover ratio is presently 0.6 days. Approximately 3.6% of the company’s shares are short sold. Approximately 3.6% of the company’s shares are short sold. Based on an average daily trading volume, of 17,953 shares, the days-to-cover ratio is presently 0.6 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Csenge Advisory Group bought a new position in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 12,421 shares of the company’s stock, valued at approximately $163,000. Csenge Advisory Group owned 6.54% of ProShares UltraShort Nasdaq Biotechnology at the end of the most recent reporting period.

ProShares UltraShort Nasdaq Biotechnology Stock Down 1.8%

Shares of BIS traded down $0.15 during midday trading on Friday, reaching $8.41. The company had a trading volume of 5,930 shares, compared to its average volume of 14,467. ProShares UltraShort Nasdaq Biotechnology has a 1-year low of $8.31 and a 1-year high of $25.87. The firm has a 50 day simple moving average of $8.92 and a 200-day simple moving average of $10.89.

ProShares UltraShort Nasdaq Biotechnology Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 31st. Investors of record on Wednesday, December 24th were given a dividend of $0.1026 per share. This represents a $0.41 annualized dividend and a yield of 4.9%. The ex-dividend date was Wednesday, December 24th.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.